Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease
Clinical trial NCT01048229 · TERMINATED
Trial details
- NCT number
- NCT01048229
- Sponsor
- Qualissima
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2010-03-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.